OverviewChartNewsTraderScreen

HSBC Call 30 JEN 19.06.2024/  DE000HG7ARB1  /

EUWAX
2024-05-21  8:27:03 AM Chg.0.000 Bid5:35:02 PM Ask5:35:02 PM Underlying Strike price Expiration date Option type
0.001EUR 0.00% 0.001
Bid Size: 10,000		 0.065
Ask Size: 10,000		 JENOPTIK AG NA O.N. 30.00 - 2024-06-19 Call
GlobeNewswire 05-17 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 05-01 Jennifer Leggio Joins Tidal Cyber as Chief Operating Officer Amid Strong Business Growth
GlobeNewswire 05-01 Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on ...
GlobeNewswire 04-30 Iovance Biotherapeutics to Present at Upcoming Conferences
GlobeNewswire 04-24 Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
GlobeNewswire 04-24 Navient posts first quarter 2024 financial results
GlobeNewswire 04-23 Wind Harvest Surpasses $500K Milestone on Netcapital, Offers Limited-Time Discounted Shares
GlobeNewswire 04-19 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 04-17 Hain Celestial Announces Fiscal Third Quarter 2024 Results Conference Call and Webcast
TeleTrader 04-11 US: Russian hackers stole gov't emails in Microsoft cyberattack
GlobeNewswire 04-11 Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...
GlobeNewswire 04-10 Navient to announce first quarter 2024 results, host earnings webcast April 24
GlobeNewswire 04-02 2XO Kentucky Straight Bourbon Whiskey Releases The Kiawah Blend, Renowned Blender Dixon Dedman’s Fou...
GlobeNewswire 03-22 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 03-18 Weebit Nano to demo its ReRAM technology on GlobalFoundries’ 22FDX® platform
GlobeNewswire 03-04 Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Tri...
GlobeNewswire 03-01 Iovance Biotherapeutics to Present at Upcoming Conferences
GlobeNewswire 02-22 Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call ...
GlobeNewswire 02-21 Weebit Nano demonstrates performance of its ReRAM under extended automotive conditions
GlobeNewswire 02-20 Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stoc...
GlobeNewswire 02-16 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 02-16 Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
GlobeNewswire 02-15 Navient declares first quarter common stock dividend
GlobeNewswire 02-01 Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Confer...
GlobeNewswire 01-31 Navient posts fourth quarter 2023 financial results